Connect with others who understand.

Sign up Log in
Resources
About MyMyelomaTeam
Powered By
Real members of MyMyelomaTeam have posted questions and answers that support our community guidelines, and should not be taken as medical advice. Looking for the latest medically reviewed content by doctors and experts? Visit our resource section.

Can A Patient Be Treated With One Of These Therapies If The Relapse Happens 18 Months Of A Successful CAR T Transplant?

A MyMyelomaTeam Member asked a question šŸ’­
January 22
ā€¢
View reactions
Multiple Myeloma Treatment: BCMA-Targeted Immunotherapy Read Article...
A MyMyelomaTeam Member

Yes, you can be treated with a new bispecific, or revisit some of your older treatments in different combinations.

July 20
A MyMyelomaTeam Member

I agree on both counts. My husband had been under his care for over eight years and he is the best. He owes his life to Dr Landgren. He is truly another member of our family, the same as is his assistant Dennis. What a team! Empathetic, extremely knowledgeable, positive and forward thinking. We are from VA and have followed him from NYC to Miami. Cannot recommend him enough!

January 23
A MyMyelomaTeam Member

I think the answer is yes. I just watched a webinar about this. It's better to do CAR t then go to the bispecifics. Something about t cell exhaustion. I'm still trying to figure out these new treatments. šŸ’•

January 23
A MyMyelomaTeam Member

If a patient relapses 18 months after a successful CAR T-cell therapy, there are several treatment options available:

1. Restarting Original Therapy: If remission lasted at least six months to one year, reintroducing the initial therapy might be considered
2. Another Bone Marrow Transplant: If the patient had an Show Full Answer

If a patient relapses 18 months after a successful CAR T-cell therapy, there are several treatment options available:

1. Restarting Original Therapy: If remission lasted at least six months to one year, reintroducing the initial therapy might be considered.
2. Another Bone Marrow Transplant: If the patient had an autologous bone marrow transplant (ASCT) and experienced several years of remission, another ASCT might be recommended.
3. New Therapies: New treatment options, including other CAR T-cell therapies, monoclonal antibodies, or bispecific T-cell engagers, might be considered.

The specific treatment plan would depend on the patient's overall health and previous treatment history.

July 20
A MyMyelomaTeam Member

šŸ’•šŸ’–

January 23

Related content

View All

Hello My Beautiful MM Family, I Had A SCT, In October, Iā€™m Feeling Great, What Are The Chances Of Relapsing After A Sct? Thank You

A MyMyelomaTeam Member asked a question šŸ’­
Prospect Park, PA

Is It Correct That Myeloma Will Relapse Regardless Of Treatment Options (including Stem Cell Transplant)?

A MyMyelomaTeam Member asked a question šŸ’­
Dallas, TX

Any High Risk Folks With Long Post Transplant Remission? What Is Your Treatment Plan?

A MyMyelomaTeam Member asked a question šŸ’­
Valdez, AK
Continue with Facebook
Continue with Google
By joining, you accept our Terms of Use, and acknowledge our collection, sharing, and use of your data in accordance with our Health Data Policy and Privacy policies.Your privacy is our priority Lock Icon
Already a Member? Log in